Loading...
Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy
Abravan, Azadeh Price, Gareth J Banfill, Kathryn Marchant, Thomas E Craddock, Matthew Wood, Joe Aznar, Marianne Camille McWilliam, Alan Faivre-Finn, Corinne
Abravan, Azadeh
Price, Gareth J
Banfill, Kathryn
Marchant, Thomas E
Craddock, Matthew
Wood, Joe
Aznar, Marianne Camille
McWilliam, Alan
Faivre-Finn, Corinne
Citations
Altmetric:
Abstract
Radiation-induced heart disease (RIHD) is a recent concern in patients with lung cancer after being treated with radiotherapy. Most of information we have in the field of cardiac toxicity comes from studies utilizing real-world data (RWD) as randomized controlled trials (RCTs) are generally not practical in this field. This article is a narrative review of the literature using RWD to study RIHD in patients with lung cancer following radiotherapy, summarizing heart dosimetric factors associated with outcome, strength, and limitations of the RWD studies, and how RWD can be used to assess a change to cardiac dose constraints.
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Article
Citation
Abravan A, Price G, Banfill K, Marchant T, Craddock M, Wood J, et al. Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy. Frontiers in oncology. 2022;12:934369. PubMed PMID: 35928875. Pubmed Central PMCID: PMC9344971. Epub 2022/08/06. eng.